Table 3.
Comparison of Xrs values in the studied groups.
| Xrs (hPa sL−1) Xrs (% norm) |
AK | ANK | K |
|---|---|---|---|
| Total | −4.76∗ | −7.31∗∗ | −2.11^ |
| (95% CI: −5.21; −3.32) | (95% CI: −8.21; −5.54) | (95% CI: −3.09; −1.12) | |
|
| |||
| Inhaled | −4.34∗ | −6.71∗∗ | −1.84^ |
| (95% CI: −5.68; −3.12) | (95% CI: −7.1; −5.89) | (95% CI: −2.81; −0.82) | |
|
| |||
| Exhaled | −5.76∗ | −8.49∗∗ | −2.89^ |
| (95% CI: −7.02; −4.12) | (95% CI: −9.91; −7.52) | (95% CI: −3.81; −1.19) | |
|
| |||
| Δ Xrs | 0.42 | 0.46 | 0.39 |
| (95% CI: 0.36–0.51) | (95% CI: 0.41–0.62) | (95% CI: 0.29–0.47) | |
AK: patients with controlled asthma; ANK: patients with uncontrolled asthma; K: control group; Δ Xrs: the difference between the inspiration and expiration component of the reactance; significant differences (ANOVA test) between the following: ∗AK and K, p < 0.05; ∗∗ANC and K, p < 0.05; ^AK and ANC, p < 0.05.